duloxetine hydrochloride has been researched along with Drug Withdrawal Symptoms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bratton, RH; Ward, SA | 1 |
| Benasi, G; Cosci, F; Fava, GA; Guidi, J; Lucente, M; Offidani, E | 1 |
| Charkhpour, M; Ghanbarzadeh, S; Ghavimi, H; Jafari, RM; Parvizpur, A | 1 |
| Hou, YC; Lai, CH | 1 |
| Cutler, N | 1 |
| Abdy, NA; Gerhart, K | 1 |
| Desaiah, D; Haddad, PM; Kajdasz, DK; Perahia, DG | 1 |
| Ball, S; Detke, M; Dinkel, J; Dunayevich, E; Erickson, J; Hartford, J; Kornstein, S; Liebowitz, M; Pigott, T; Russell, J; Walker, D | 1 |
| Dunner, DL; Fava, M; Kornstein, S; Munoz, R; O'Reardon, J; Trivedi, M; Wilson, M; Wohlreich, M | 1 |
| Hsiao, MC; Liu, CY | 1 |
| Huguelet, P; Perroud, N; Relecom, C | 1 |
2 review(s) available for duloxetine hydrochloride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
Topics: Adrenergic Uptake Inhibitors; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Mood Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2018 |
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Humans; Long-Term Care; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Thiophenes | 2005 |
2 trial(s) available for duloxetine hydrochloride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Male; Middle Aged; Patient Dropouts; Personality Inventory; Psychometrics; Recurrence; Substance Withdrawal Syndrome; Thiophenes; Treatment Outcome | 2008 |
8 other study(ies) available for duloxetine hydrochloride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Physical Dependence in Patient With Chronic Low Back Pain Treated With Topiramate: A Case Report.
Topics: Aged; Anticonvulsants; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Receptors, Adrenergic, alpha-2; Substance Withdrawal Syndrome; Topiramate; Treatment Outcome | 2019 |
Duloxetine attenuated morphine withdrawal syndrome in the rat.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes | 2014 |
Duloxetine: withdrawal syndromes.
Topics: Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes | 2013 |
Long-term duloxetine withdrawal syndrome and management in a depressed patient.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Substance Withdrawal Syndrome; Thiophenes | 2014 |
Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
Topics: Adult; Analgesics; Chronic Pain; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Neck Pain; Serotonin and Noradrenaline Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2017 |
Duloxetine withdrawal syndrome in a newborn.
Topics: Adult; Duloxetine Hydrochloride; Female; Fetus; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes | 2013 |
Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Venlafaxine Hydrochloride | 2008 |
Successful treatment of nicotine withdrawal with duloxetine: a case report.
Topics: Adult; Alcohol Drinking; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Smoking; Substance Withdrawal Syndrome; Thiophenes; Tobacco Use Disorder | 2008 |